Drug Delivery
To ensure that biotechnologically produced drugs are not recognized as foreign by the immune system and eliminated prematurely from the body, biotechnology uses different methods for modifying them so that effective drug delivery is possible.
celares gmbh is specialized in modifying biopharmaceuticals with polyethylene glycols (PEG), through which active ingredients have a longer effect in the body and are more soluble. Whereas in this technology the ingredients are chemically coupled with PEG, Alrise Biosystems GmbH encapsulates biotechnological ingredients with a microparticle envelope. This envelope prevents the drugs from decomposing in the liver, but instead allows them to be released in a controlled manner into the body.
The above technologies not only reduce side effects; the drugs also need to be taken less frequently.
Drug delivery is not only interesting for newly developed substances: Biopharmaceuticals already on the market can gain new patent protection with the aid of a new form of administration.
News innovation
Inspiring and connecting: “Talk im Cube”
For almost a year, “Talk im Cube” has been bringing science and business together on the Campus Berlin-Buch
more ...Eckert & Ziegler and Ariceum Therapeutics Sign Global Supply Agreement for the Development of Next-Generation Radiotherapeutics for Precision Cancer Treatments
Eckert & Ziegler, one of the world’s largest providers of isotopes for medical, scientific and industrial use, and Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceuti...
more ...Eckert & Ziegler: Changes in the Executive Board and Supervisory Board
The Supervisory Board of Eckert & Ziegler SE has appointed Dr. Gunnar Mann (57) as a new member of the Executive Board, effective 1 January 2025. He will assume operational responsibility for the Medi...
more ...Events Campus
17.12.2024, 08:00
Aktualisierungskurs für Projektleiter und Beauftragte für Biologische Sicherheit nach § 28 GenTSV
In Deutschland müssen Projekteiter und Beauftragte für Biologische Sicherheit gemäß § 28 Abs. 3 der aktuellen Gentechnik Sicherheitsverordnung (GenTSV) ihre Kenntnisse „mindestens alle fünf Jahre durc...
more ...07.01.2025, 16:00
Krebs und Metastasierung: Ursachen und neue Therapien
26.02.2025, 10:00
JUGEND FORSCHT – 60. Regional-Wettbewerb „Macht aus Fragen Antworten”
Die Pateneinrichtungen des Campus Berlin-Buch richten erneut den Regionalwettbewerb aus
more ...
